JP2024537906A5 - - Google Patents

Info

Publication number
JP2024537906A5
JP2024537906A5 JP2024523414A JP2024523414A JP2024537906A5 JP 2024537906 A5 JP2024537906 A5 JP 2024537906A5 JP 2024523414 A JP2024523414 A JP 2024523414A JP 2024523414 A JP2024523414 A JP 2024523414A JP 2024537906 A5 JP2024537906 A5 JP 2024537906A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
mucositis
effective amount
susceptible
human subjects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024537906A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/060007 external-priority patent/WO2023067501A1/en
Publication of JP2024537906A publication Critical patent/JP2024537906A/ja
Publication of JP2024537906A5 publication Critical patent/JP2024537906A5/ja
Pending legal-status Critical Current

Links

JP2024523414A 2021-10-18 2022-10-18 粘膜炎を処置するための組成物及び方法 Pending JP2024537906A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163257099P 2021-10-18 2021-10-18
US63/257,099 2021-10-18
PCT/IB2022/060007 WO2023067501A1 (en) 2021-10-18 2022-10-18 Compositions and methods for treating mucositis

Publications (2)

Publication Number Publication Date
JP2024537906A JP2024537906A (ja) 2024-10-16
JP2024537906A5 true JP2024537906A5 (cg-RX-API-DMAC7.html) 2025-10-27

Family

ID=86057963

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024523414A Pending JP2024537906A (ja) 2021-10-18 2022-10-18 粘膜炎を処置するための組成物及び方法

Country Status (5)

Country Link
US (1) US20240415798A1 (cg-RX-API-DMAC7.html)
EP (1) EP4419096A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024537906A (cg-RX-API-DMAC7.html)
KR (1) KR20240089762A (cg-RX-API-DMAC7.html)
WO (1) WO2023067501A1 (cg-RX-API-DMAC7.html)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1900364T3 (da) * 2001-04-18 2014-01-13 Prometic Biosciences Inc Fedtsyrer, glycerider og analoger med medium kædelængde som neutrofile overlevelses- og aktiveringsfaktorer
KR20050118057A (ko) * 2004-04-24 2005-12-15 김상희 아세틸디아실글리세롤류의 화합물을 유효성분으로함유하는 항암제 및 건강식품
US9808438B2 (en) * 2015-11-09 2017-11-07 Enzychem Lifesciences Corporation Method for treating mucositis
IL274974B2 (en) * 2017-11-30 2025-03-01 Enzychem Lifesciences Corp Compositions for prevention or treatment of acute radiation syndrome

Similar Documents

Publication Publication Date Title
Rasmussen et al. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis
ES2301142T3 (es) Combinaciones que comprenden inhibidores de dipeptidilpeptidasa-iv y agentes antidiabeticos.
JP6353577B2 (ja) 組み合わせ組成物
EP4110326B1 (en) Combination comprising alpelisib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid
WO2022218958A1 (en) Combination comprising everolimus and amcenestrant
ES3060114T3 (cg-RX-API-DMAC7.html)
EP2723448B1 (en) Compositions for the treatment of chronic fatigue
CN103533940A (zh) 治疗晚期实体瘤的方法
JP2010505854A (ja) 低投与量のスタンソポルフィンを用いる幼児の高ビリルビン血症の治療
JP2023522415A5 (cg-RX-API-DMAC7.html)
JP2023548429A5 (cg-RX-API-DMAC7.html)
JP2025511402A5 (cg-RX-API-DMAC7.html)
JP2024531799A5 (cg-RX-API-DMAC7.html)
CN103596565B (zh) 塞克硝唑在口腔感染治疗中的应用
CN106507666A9 (zh) 1,3‑丙二磺酸或其药学上可接受的盐用于治疗肉样瘤病的用途
EP2727595B1 (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
JP2012031141A (ja) 骨髄異形性症候群を治療するための組成物および方法
US9532960B2 (en) Pharmaceutical composition and kit for applying metformin and sodium butyrate in Kras mutation cancer treatment
TW202317084A (zh) 新穎治療
JP2022546042A5 (cg-RX-API-DMAC7.html)
Andriiaka et al. OPTIMIZATION OF DIAGNOSIS OF SECONDARY METABOLIC DISORDERS AND TREATMENT TACTICS IN PATIENTS WITH ANEMIA IN NEOPLASTIC DISEASE IN COLORECTAL CANCER
CN111821423A (zh) 一种白介素2用于治疗慢性自发性荨麻疹的应用
RU2772293C1 (ru) Способ лечения хронического афтозного стоматита
WO2025103426A1 (zh) 白塞综合征的治疗
BR112021003578B1 (pt) Composição e método para erradicar helicobacter pylori